DBL Group, country’s one of the top business conglomerates, has started their journey in the pharmaceutical industry after their success in export based readymade garment products and ceramic tiles, according to a statement.
Zahid Maleque, minister for health and family welfare, inaugurated the Tk 7.0 billion factory located at Kashimpur, Gazipur following the guidelines of US FDA, WHO, GMP.
Dr Habib-E-Millat MP, Maj Gen Md Mahbubur Rahman, director general of DGDA, and Prof Dr SM Abdur Rahman, dean, Faculty of Pharmacy, University of Dhaka were present in this occasion as special guests.
From DBL Group, its Chairman Abdul Wahed, Managing Director MA Jabbar, Vice Chairman MA Rahim, and Deputy Managing Director and Group CEO MA Quader were present among other high officials.
Health minister mentioned the success in fighting Covid-19 by successful vaccination programmes. He also emphasised, “The number of affected cases considering Bangladesh population is low if we compare with many other countries specially with our neighbouring country India. Definitely, it is a sign of improvement of our health sector.”
He expressed his expectations of seeing high quality products from DBL Pharmaceuticals Limited as DBL has already set its standard in a high position at all their previous factories, investments, and projects.
Managing Director of DBL MA Jabbar said in his welcome speech, “Sustainable development and sound technology are in the keynotes of DBL Group. The pharma factory of DBL will have the same reflection. We have already stepped in the Unites States of America through contract manufacturing by one of our sister concerns DBL Pharmaceuticals Inc. They are marketing two generic medicines in USA with success. In near future, we have plans and are hopeful that we will directly export products manufactured in this plant (Gazipur, Kashimpur) to USA along with other developed countries.”
